RAPT Therapeutics Competitors and Similar CompaniesClear all
RAPT Therapeutics's competitors and similar companies include Kiromic Biopharma.
 RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. |  Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. | |
Founding Date | Founding Date 2015 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Houston, US HQ |
Employees | Employees 64 | Employees 4426% increase |
Valuation ($) | Valuation ($) 69.8 m | Valuation ($) 1.8 m |
Financial | ||
Net income | Net income ($129.9m) (FY, 2024) | Net income ($26.9m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 176m | Total funding raised $ 135k |
For sources of this data, please see the company profile
View Company Profiles
Kiromic Biopharma
HQ
Houston, US
Employees
44↑ 26% increase
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company